In The USA Scientists Have Found The New Causes Of Glaucoma

In The USA Scientists Have Found The New Causes Of Glaucoma.
Glucosamine supplements that millions of Americans arrogate to employee freebie wise and knee osteoarthritis may have an unexpected side effect: They may increment risk for developing glaucoma, a small new study of older adults suggests in May 2013. Glaucoma occurs when there is an improve of intraocular pressurize (IOP) or pressure inside the eye detox. Left untreated, glaucoma is one of the primary causes of blindness.

In the late study of 17 people, whose average age was 76 years, 11 participants had their glad eye pressure measured before, during and after taking glucosamine supplements. The other six had their look pressure leisurely while and after they took the supplements. Overall, pressure inside the visual acuity was higher when participants were taking glucosamine, but did return to normal after they stopped taking these supplements, the workroom showed.

So "This study shows a reversible clout of these changes, which is reassuring," wrote researchers led by Dr Ryan Murphy at the University of New England College of Osteopathic Medicine in Biddeford, Maine. "However, the feasibility that unchanging check can result from prolonged use of glucosamine supplementation is not eliminated. Monitoring IOP in patients choosing to annexe with glucosamine may be indicated".

Exactly how glucosamine supplements could touch pressure inside the eye is not fully understood, but several theories exist. For example, glucosamine is a harbinger for molecules called glycosaminoglycans, which may elevate guard pressure. The findings are published online May 23 as a fact-finding note in JAMA Ophthalmology.

E-mail reminder to the survey

E-mail reminder to the survey.
Both electronic and mailed reminders cure spur on some patients to get colorectal cancer screenings, two renewed studies show. One turn over included 1103 patients, aged 50 to 75, at a set practice who were overdue for colorectal cancer screening. Half of them received a individual electronic message from their doctor, along with a tie to a Web-based tool to assess their risk for colorectal cancer. The other patients acted as a device group and did not receive any electronic messages hartsville. One month later, the screening rates were 8,3 percent for patients who received the electronic reminders and 0,2 percent in the steer group.

But the inconsistency was no longer significant after four months - 15,8 percent vs 13,1 percent. Among the 552 patients who received the electronic message, 54 percent viewed it and 9 percent old the Web-based assessment tool. About one-fifth of the patients who employed the assessment work were estimated to have a higher-than-average endanger for colorectal cancer.

Patients who utilized the jeopardy gizmo were more likely to get screened. "Patients have expressed involvement in interacting with their medical record using electronic portals equivalent to the one used in our intervention," wrote Dr Thomas D Sequist, Brigham and Women's Hospital and Harvard Medical School, and colleagues, in a newscast release.